IgM/IgG Rapid Tests
Delivering A Robust Methodology To Test and Treat Every
Case In Order To Break The Chains of Transmission
A Smarter Strategy To Move Past The CoV-19 Pandemic
When Serology Antibody Testing is adequately planned and routinized, the methodology is likely to lead to an effective scaled approach for Critical and General COVID-19 population screening: the basis of our Rapid Testing strategy is the finger-stick testing modality with IgG/IgM test kits.
The sheer speed of our Rapid Test and turn-around time presents the most immediately impactful benefit of POCT in unleashing the power of a fast action 4-10 minute identification of the infected Patient.
1 Sample Well Or 2 Sample Wells. Your Choice
FDA Emergency Use Authorized
Rapid serology test for the qualitative detection of SARS-CoV-2 IgG and IgM antibodies in venous whole blood, serum and plasma
SARS-CoV-2 total antibody rapid Test. Intended for screening of patients suspected of COVID-19 infection. Lateral Flow Test – suitable for rapid, on-site testing. Performance: sensitivity of 94.70% (125/132) and specificity of 98.89% (268/271). The test has been clinically validated during the 2020 COVID-19 outbreak in China.
Easy-to-use: No special equipment. Works with whole blood, serum or plasma samples Fast: Clear answer within only 15 minutes.